Intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic prostate cancer: a systematic review and meta-analysis
Authors:
- Tobias Engel Ayer BotrelTBTobias Engel Ayer Botrel
- Otávio ClarkOCOtávio Clark
- Rodolfo Borges dos ReisRRRodolfo Borges dos Reis
- Antônio Carlos Lima PompeoAPAntônio Carlos Lima Pompeo
- Ubirajara FerreiraUFUbirajara Ferreira
- Marcus Vinicius SadiMSMarcus Vinicius Sadi
- Francisco Flávio Horta BretasFBFrancisco Flávio Horta Bretas
Open Access
- 25 January 2014
- journal article
- review article
- Published by Springer Nature in BMC Urology
- Vol. 14 (1) , 9
Abstract
Prostate cancer is the most common cancer in older men in the United States (USA) and Western Europe. Androgen deprivation (AD) constitutes, in most cases, the first-line of treatment for these cases. The negative impact of CAD in quality of life, secondary to the adverse events of sustained hormone deprivation, plus the costs of this therapy, motivated the intermittent treatment approach. The objective of this study is to to perform a systematic review and meta-analysis of all randomized controlled trials that compared the efficacy and adverse events profile of intermittent versus continuous androgen deprivation for locally advanced, recurrent or metastatic hormone-sensitive prostate cancer.Keywords
This publication has 60 references indexed in Scilit:
- Treatment of Prostate Cancer With Intermittent Versus Continuous Androgen Deprivation: A Systematic Review of Randomized TrialsJournal of Clinical Oncology, 2013
- 777 POOLED ANALYSIS OF TWO PROTOCOLS OF INTERMITTENT HORMONAL THERAPY IN ADVANCED PROSTATIC CANCERJournal of Urology, 2013
- Intermittent Androgen Suppression for Rising PSA Level after RadiotherapyNew England Journal of Medicine, 2012
- Intermittent versus Continuous Androgen Suppression Therapy: Do We Have Consensus Yet?Current Oncology, 2010
- Emerging cardiometabolic complications of androgen deprivation therapyThe Aging Male, 2010
- Intermittent androgen deprivation—questions remainNature Reviews Urology, 2009
- Guideline for the Management of Clinically Localized Prostate Cancer: 2007 UpdateJournal of Urology, 2007
- International study into the use of intermittent hormone therapy in the treatment of carcinoma of the prostate: a meta‐analysis of 1446 patientsBJU International, 2007
- Measuring inconsistency in meta-analysesBMJ, 2003
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986